دانلود کتاب بررسی و ارزیابی بیماری قلبی براونوالد

For decades now, molecular imaging has played a foundational role in the evaluation of cardiovascular pathology focusing primarily on the assessment of coronary artery disease and systolic function. More recently, the increasing availability of PET imaging has led to significant evolution in the field of molecular cardiovascular imaging. In particular, FDG-PET, which had long been used for the imaging of noncardiac infection, inflammation, and malig­nancy, has revealed itself to be immensely useful in a number of cardiovascu­lar applications. Today, many centers offer routine cardiovascular PET imaging for a number of indications, ranging from the evaluation of infection (e.g., endocarditis), inflammatory processes (e.g., cardiac sarcoidosis), car­diac malignancy, as well as other applications such as viability imaging. Furthermore, technological advances have brought forth a new imaging modality, PET/MR, for which the implications for cardiac imaging are still being determined.